Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00282854 · ClinicalTrials.gov registry record

Genetics of Rolandic Epilepsy

A clinical trial, sponsored by King's College London.

Completed
Registry status
1,000
Enrollment target

NCT00282854: Completed study, sponsored by King's College London.

NCT00282854 is a clinical trial that has completed, run by King's College London. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00282854 has completed, sponsored by King's College London.

COMPLETED
Registry status
1,000 participants
Enrollment target

Study Summary

The purpose of this study is to find the genes that cause Rolandic epilepsy and its related traits.

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2005-01
Est. Completion 2013-12
King's College London

5 total trials

What the finished NCT00282854 record still lists

NCT00282854 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00282854 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00282854 about?

NCT00282854 is a clinical study titled "Genetics of Rolandic Epilepsy". The purpose of this study is to find the genes that cause Rolandic epilepsy and its related traits.

What is the current status of trial NCT00282854?

This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2005-01. Estimated completion is 2013-12.

Who is sponsoring clinical trial NCT00282854?

This trial is sponsored by King's College London, which has 5 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00282854, the US trial registry maintained by the National Library of Medicine. NCT00282854 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.